|
HS Code |
312134 |
| Compound Name | 1-Cyclohexenylacetic Acid |
| Cas Number | 2641-09-4 |
| Molecular Formula | C8H12O2 |
| Molecular Weight | 140.18 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Density | 1.057 g/cm3 |
| Boiling Point | 265 °C |
| Solubility In Water | Slightly soluble |
| Refractive Index | 1.487 |
| Smiles | C1CCC(=CC1)CC(=O)O |
As an accredited 1-Cyclohexenylacetic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1-Cyclohexenylacetic Acid, 100g, supplied in a tightly sealed amber glass bottle with a hazard label and chemical identification. |
| Shipping | 1-Cyclohexenylacetic Acid is shipped in secure, tightly sealed containers to prevent leaks or contamination. It should be transported at ambient temperature, away from strong oxidizers. Proper labeling and documentation are provided according to regulatory standards. Handle with care to avoid exposure and ensure compliance with safety and environmental guidelines during transit. |
| Storage | 1-Cyclohexenylacetic acid should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from sources of ignition and incompatible substances such as strong oxidizers. Protect from moisture and direct sunlight. Keep container tightly closed when not in use to prevent contamination and degradation. Store at room temperature unless otherwise specified by the manufacturer. |
Applications of 1-Cyclohexenylacetic Acid in Industrial ManufacturingAs an established manufacturer of 1-Cyclohexenylacetic Acid, we focus on its practical integration across distinct downstream industrial sectors. Below, we outline the primary application scenarios where this raw material sees real usage, ensuring each segment details industry-specific regulatory requirements, formulation ratios, relevant processing stages, and representative finished products. 1. Pharmaceutical Intermediate for Nonsteroidal Anti-Inflammatory Drug SynthesisOur 1-Cyclohexenylacetic Acid is commonly introduced as an essential building block in the synthesis of certain nonsteroidal anti-inflammatory drug (NSAID) APIs, such as derivatives structurally related to indomethacin and its analogs. Manufacturers utilize this intermediate during key Grignard and nucleophilic substitution steps to construct the cyclohexenylacetic backbone prior to the final condensation with active aromatic or heteroatom-containing moieties. Precise incorporation during the early API stages enables reliable batch consistency aligned with GMP requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Plant Growth Regulator Precursor in Agrochemical SynthesisDownstream crop protection and specialty fertilizer companies employ our material as a precursor for the synthesis of certain auxin-like plant growth regulator molecules, particularly cyclohexene-based auxinic acids analogs. The raw material is esterified or otherwise functionalized to produce customized PGRs that modulate cell elongation and differentiation processes in various crop species. Integration occurs within multi-step organic synthesis sequences, requiring tight control over acid purity and reactivity to ensure downstream biological activity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical Intermediate for Fragrance Ingredient ProductionThe compound serves as a selective intermediate in the controlled synthesis of cyclohexene ring-containing aroma chemicals, especially musk and woody note molecules. Fragrance ingredient manufacturers utilize this material during key Friedel–Crafts alkylation and oxidation steps to achieve structurally defined target molecules with consistent olfactory properties crucial for bulk perfume and essence blending. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Synthesis of Advanced Polymer ModifiersLeading performance polymer manufacturers adopt 1-Cyclohexenylacetic Acid to engineer flexible side chains in specialty polyesters and copolyesters, enhancing flexibility, glass transition temperature, and impact resistance. The acid group undergoes direct esterification in melt or solution polycondensation reactions, requiring highly controlled feed ratios and in-process QC to ensure copolymer purity and long-term thermal stability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Solvent Precursor for Electronic Materials ManufactureProducers of high-purity electronic-grade solvents occasionally utilize this acid as a starting compound in the synthesis of customized ester solvents, valued in photoresist and advanced cleaning formulations for microelectronics. Its use in transesterification and hydrogenation reactions enables the creation of solvents with targeted polarity and volatility profiles, suitable for applications demanding ultra-low trace metal content and controlled evaporation rates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-Cyclohexenylacetic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Any chemist who works with synthetic intermediates knows that small differences in molecular structure often influence reaction outcomes far more than expected. Over our decades manufacturing advanced carboxylic acids, we have seen changing demand for specific molecules based on new process technologies and updated regulatory guidance. 1-Cyclohexenylacetic acid stands out. Its distinct combination of cyclohexene and acetic acid functions opens up synthesis avenues that neither component alone can offer. Our facility focuses on producing this compound to high purity for those who require reliability and batch-to-batch consistency.
For everyone involved in organic synthesis, the molecular structure of 1-cyclohexenylacetic acid brings something hard to substitute. With a six-carbon ring containing a double bond and a carboxylic side chain, this molecule covers ground that neither plain cyclohexene nor basic alkyl acids reach. The unsaturated ring survives under conditions that degrade typical cyclohexyl acids; the acetic group provides functionalization points that pure cyclohexenes lack. Over the years, we have seen research chemists and process teams turning to this acid not for theoretical curiosity, but because nothing else matches its balance of stability, reactivity, and ease of downstream modification.
Industrial chemistry teaches hard lessons about the pitfalls of variable quality. Small slippages in impurity profiles complicate purification and reduce yields across large production runs. Our laboratory began with simple benchtop synthesis, scaling up as demand emerged from pharmaceuticals and agrochemicals. With this growth came tighter controls, continuous feedback loops, and routine trace impurity monitoring. Years of investment in analytical methods—HPLC, GC-MS, wet chemistry for functional groups—ensure the acid leaves our lines in a form suitable for direct use or further derivatization.
We keep our processes transparent and adaptive. Over time, solvent recovery and energy optimization improved sustainability. Trace isomer formation during hydrogenation worried some clients, so we adjusted our catalyst system to keep side-products at undetectable levels. Some research partners require grams for pilot work, others order metric tons for full production. Rather than stick to a single model, we designed batch scales to flex. What matters most is that our 1-cyclohexenylacetic acid reaches partners with the specifications they trust, every time, because unpredictable feeds disrupt downstream reactions and delay time-to-market.
In pharmaceutical synthesis, ring systems with accessible reactive handles play key roles. Few intermediates combine the partial unsaturation of cyclohexenyl rings with an acetic acid group ready for further coupling. Medicinal chemists find ways to attach this acid to nitrogen centers or use palladium cross-coupling conditions to build larger skeletons. At our factory, we have seen the final active ingredients these methods generate. One cycle in the process might introduce an aromatic ring to the structure; a later step could create a bridge or insert a nitrogen. The cyclohexenyl group resists certain reductions, keeping integrity under harsh steps, while the carboxylic acid domain offers versatile routes forward.
Agrochemical manufacturers approach us for similar reasons. Cyclohexenylacetic acid supports the core modifications they need for certain growth regulators or protective agents. Our technical teams have supported trials involving esterification, amide formation, and oxidative transformations. These clients appreciate consistent melting points and robust solubility, which allow them to manage their batch reactors efficiently. Over many campaigns, feedback has pushed us to improve drying, filtration, and fine-tuning of particle size to suit different equipment setups.
Often, purchasers compare 1-cyclohexenylacetic acid with cyclohexylacetic acid, cyclohexene derivatives, or simple alkyl acetic acids. Subtle deviations in their chemical properties create very real divergences in application. Cyclohexylacetic acid lacks the double bond, limiting its usefulness in routes that exploit conjugate addition or ene reactions. Basic acetic acid or its plain C2 through C4 analogs offer the carboxyl group, but with none of the ring strain and unsaturation that facilitate selective transformations. By contrast, 1-cyclohexenylacetic acid’s unsaturated ring modulates electron density and opens specific reactivity channels. We have observed its adoption in reaction cascades where the starting geometry must be controlled, or where later ring-opening is tailored to generate non-linear architectures.
Cyclohexene itself, though useful as a volatile hydrocarbon, fails to deliver the handle that downstream functionalization requires. Our acid’s carboxylic group makes it compatible with activation reagents—EDC, DCC, DTTA, and others—allowing rapid coupling to amines or alcohols. Many specialty manufacturers report better selectivity under mild conditions compared to simple cycloalkenes.
Academic teams often evaluate new coupling partners and ring systems in multi-gram scale. These groups care about reproducible reaction profiles and easy analytical tracking. They seek single, sharp melting points and well-resolved NMR shifts. To meet these needs, our plant ensures purity surpassing 98% by both HPLC and GC, with water and residual solvent levels kept much lower than typical benches achieve. Impurity spectra stay consistent; batches from different months line up in downstream performance.
Process chemists scaling operations to hundreds of kilograms face other challenges. Consistency matters in every crystal and powder lot. Over the years, our technical exchanges highlighted practical constraints in solid-handling, dust suppression, and bulk storage. We modified drying procedures and anti-caking agents based on real factory feedback: too much residual moisture means clumping in storage bins; impurities above 1-2% generate haze in solution and require extra purification steps. We continuously gather reports from large reactors to improve the flow, solubility, and shelf life of our material.
High-throughput discovery campaigns further expand the needs. Chemoinformatics drives exploration of related structures; combinatorial synthesis protocols favor intermediates that react cleanly and tolerate diverse conditions. We make sure our acid handles heating, varying pH, and long-standing room temperature storage without rapid degradation or phase separation. As a result, screens using our material fed directly into research reports and later commercialized routes.
Real-world synthesis never allows chemical shortcuts. Consistent documentation and traceability—test results, batch records, and verified chain of custody—give clients peace of mind. We have registered our synthesis pathway and routinely update environmental impact statements. Audit teams visit yearly, examining our supply chain for hazardous byproduct minimization. We provide full spectral analysis packages with every shipment, far more than minimal regulatory guidelines demand. Clients in the United States or Europe have different preferences for allowable trace metals, solvent residues, and ring impurities. Our analytical team flags trends before they become process deviations.
By focusing on actual manufacturing data rather than spec sheet minimums, our staff catches process drift or batch-to-batch anomalies before bottles leave the warehouse. This culture comes from years spent troubleshooting our own production runs, where single unreported impurity events cost time and customer trust.
Raw material sourcing shapes every production run. High-purity cyclohexene, reliable acetic anhydride, and catalyst reliability all figure into final product quality. Over nearly two decades, we have locked in verified suppliers and built redundancy into incoming inspections—infrared analysis, rapid titration to rule out hidden stabilizer loads, gas chromatography for odd contaminants. Even then, new environmental regulations or supply chain disruptions force continual review.
We keep process waste minimized through catalyst recovery and smart phase separation. Typical synthesis routes generate aqueous-organic biphasic systems; efficient filtration and phase control preserve final acid purity. Waste stream management matters not only for environment but also for overall business health: local regulators now require annual certification that our effluent loads meet modern standards. Over the last five years, incremental changes have cut energy input and waste by a measurable percent—a direct result of operator feedback guiding plant modification.
Some of the largest pharmaceutical projects we’ve collaborated on began as gram-scale tests of this acid. One research group sought a precursor for a novel central nervous system drug candidate—using our material, they unlocked a scalable route that performed better in pilot reactors than in the lab. One reason: the unique ring strain and unsaturation of our acid accelerated a cyclization step that competitors’ material failed to promote in large batches. Their success translated into repeat orders as their process went commercial.
Agricultural projects have followed similar stories. In one campaign, an agrochemical company developing a new plant growth modifier discovered that 1-cyclohexenylacetic acid’s unsaturated ring structure allowed for esterification yielding a stronger, more persistent effect compared to saturated analogs. Our consistent purity meant their pilot plants converted every last batch with near-quantitative yields, improving both project timelines and regulatory data packages.
In one fine chemical division, a specialty polymer manufacturer reported that standard alkyl acids failed to deliver the reactivity they needed for their chain termination step. Swapping in 1-cyclohexenylacetic acid allowed them to adjust end-group functionality and tune material performance for high-value industrial customers. A slight adjustment in their reactor feed—guided by data we shared regarding solubility and melting point—transformed their process economics and opened doors to new market segments.
Having tighter control over product every stage—from synthesis through isolation and final packaging—helps us respond directly to client needs. Distributor-driven models can mask root causes of quality issues; our direct relationship with end users creates faster feedback and clearer improvement cycles.
Clients who reach out for process troubleshooting or application advice are always speaking to chemists who know both the practical limits and the potential of this acid. We share spectrum data, thermal stability curves, and application notes from previous projects. Many R&D teams use this baseline to qualify new approaches: knowing our batch doesn’t shift in behavior from season to season removes a variable they otherwise can’t control.
The field keeps moving. Green chemistry guidelines tighten emissions targets, so production must keep adapting. New reaction types arise—photoredox, flow chemistry, biocatalysis—all demanding higher purity, lower trace metal content, or new solubility profiles. We collaborate with partners to meet these developing needs. About half our ongoing projects focus on method refinements: alternate solvent systems, hydrogenation condition improvements, and scale-out pilot runs to validate process changes before rollout.
As government and end user standards evolve, our documentation and compliance continue to track stricter points. Clients now request files for every incoming analytical run, expanded impurity fingerprinting, solvent recoverability data, and environmental impact summaries. Rather than surrender these to outside auditors alone, we train staff to understand both upstream sourcing risks and downstream application concerns. Direct contact between our lab teams and project managers outside allows rapid realignment when standards shift.
All chemical producers confront challenges that can’t be understood from behind a spreadsheet or spec sheet. Real-world manufacturing means plenty of time battling crystallization quirks, phase separation headaches, or irregular feedstock supply. Our commitment as a producer rests on experience, flexibility, and open lines to R&D clients who demand more than generic intermediates. Every lot of 1-cyclohexenylacetic acid we ship draws on lessons from previous runs—each batch is not just a number, but a set of adjustments made real by people on the ground. Clients rely not only on the chemistry, but also on the reliability that comes from producers who treat each order as a future relationship, not a one-time contract.
We always encourage prospective users, from pilot chemists to full-scale plant engineers, to open a technical dialogue. Each application teaches us something new—sometimes pushing us to invent process upgrades that reshape our standard product line. In this way, our work with 1-cyclohexenylacetic acid continues to build on real experience, supporting forward-thinking chemistry wherever the need arises.